申请人:Kyowa Hakko Kirin Co., Ltd.
公开号:EP2090570A1
公开(公告)日:2009-08-19
A CB2 receptor modulator comprising an imidazole derivative represented by the general formula (I):
[wherein, R1 represents optionally substituted lower alkyl or the like; R2 represents optionally substituted cycloalkyl or the like; R3 represents optionally substituted aryl or the like; and n represents an integer of 0 to 3] or a pharmaceutically acceptable salt thereof as an active ingredient, and the like are provided.
一种 CB2 受体调节剂,由通式 (I) 所代表的咪唑衍生物组成:
[其中,R1 代表任选取代的低级烷基或类似物;R2 代表任选取代的环烷基或类似物;R3 代表任选取代的芳基或类似物;n 代表 0 至 3 的整数]或其作为活性成分的药学上可接受的盐等。